Skip to main content

Table 3 Stock of sulphadoxine pyrimethamine on the day of survey, TNVS RCH Facility Survey 2005–07

From: Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania

 

2005

2006

2007

χ2 (p-value)1

All

84.7 (78.8–89.2)

[N = 190]

74.5 (67.7–80.2)

[N = 188]

59.5 (52.2–66.1)

[N = 192]

20.6 (< 0.001)

By level of facility

Dispensary

84.7 (77.9–89.6)

[N = 150]

71.3 (63.1–78.3)

[N = 136]

55.6 (47.3–63.5)

[N = 144]

19.3 (< 0.001)

Health Centre

95.2 (72.5–99.3)

[N = 21]

80.6 (62.9–91.1)

[N = 31]

72.4 (53.6–85.6)

[N = 29]

3.2 (0.04)

Hospital

73.7 (50.0–88.7)

[N = 19]

85.7 (63.6–95.3)

[N = 21]

68.4 (44.9–85.2)

[N = 19]

0.9 (0.3)

χ2 (p-value)2

1.7 (0.1)

1.3 (0.2)

1.7 (0.1)

 

By residence

Rural

84.0 (76.4–89.5)

[N = 125]

72.3 (63.9–79.4)

[N = 130]

54.9 (46.3–63.2)

[N = 133]

16.5 (< 0.001)

S-Urban

86.0 (72.1–93.6)

[N = 43]

70.7 (55.0–82.6)

[N = 41]

61.9 (46.4–75.3)

[N = 42]

3.5 (0.03)

Urban

86.4 (64.9–95.6)

[N = 22]

100

[N = 17]

88.2 (62.9–97.1)

[N = 17]

1.2 (0.2)

χ2 (p-value)2

0.07 (0.9)

3.3 (0.03)

3.5 (0.03)

 
  1. χ2 (p-value)1 for difference between survey years
  2. χ2 (p-value)2 for difference within survey years